Bioqual Inc. (BIOQ)
OTC
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
30.6452 wk Range
30.64Overview - BIOQ - Bioqual Inc.
Key Statistics
Valuation
Enterprise Value
44.09M
P/E (Trailing)
11.83
PEG Ratio
-0.07
Price / Sales (TTM)
0.68
Price / Book
0.84
EV / EBITDA
-19.56
Profitability
Gross Margin
9.16%
Profit Margin
-10.43%
Operating Margin
-24.82%
Return on Assets
-4.45%
Return on Equity
-12.16%
Ownership
Shares Outstanding
894.41K
Float
205.67K
Held by Insiders
0.00%
Held by Institutions
0.00%
Price stats
Beta
-0.0080
50-Day Avg
32.85
200-Day Avg
34.97
Dividends
Payout Ratio
14.63%
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BIOQ - Bioqual Inc.
Peers - BIOQ - Bioqual Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on OTC.
Profile Summary - BIOQ - Bioqual Inc.
About
Bioqual Inc. is a biotechnology company that specializes in providing contract research services to government and commercial clients. Its primary function is to support the biomedical research community by offering preclinical lab services that include the development and testing of vaccines, therapeutics, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
